trametinib
novartis
['trametinib', 'improve ']
 - in subset (about 17%) of pts with braf v600-mutant tumors debrafenib + trametinib improve median pfs to 20.1 months (vs 7.4m with chemo) [#asco22 abstract lba2002] full story to follow. 
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.